- ¥4tn
- ¥4tn
- ¥922bn
- 94
- 19
- 94
- 81
Annual balance sheet for Terumo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 167,113 | 200,830 | 205,311 | 187,384 | 206,354 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 133,473 | 129,280 | 136,776 | 153,555 | 180,047 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 460,607 | 523,966 | 558,713 | 611,396 | 722,116 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 264,407 | 299,679 | 333,864 | 370,869 | 415,845 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,241,355 | 1,351,192 | 1,473,693 | 1,602,225 | 1,831,402 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 211,845 | 211,366 | 177,721 | 218,001 | 379,152 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 486,541 | 494,530 | 461,380 | 491,162 | 504,312 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 754,814 | 856,662 | 1,012,313 | 1,111,063 | 1,327,090 |
Total Liabilities & Shareholders' Equity | 1,241,355 | 1,351,192 | 1,473,693 | 1,602,225 | 1,831,402 |
Total Common Shares Outstanding |